Nelson-Rees and Flandermeyer have (1) indicted the Chang liver cell (2) as a HeLa cell contaminant. They have concluded that, regardless of designation, the Chang cell should be considered a de facto strain of HeLa. These authors based their conclusion on the following: (i) the electromobility of glucose-6-phosphate dehydrogenase (G6PD) and phosphoglucomutase of the Chang cell were similar to those of the HeLa cell; (ii) the Chang cell contained a complex of rearranged chromosomes or (6) and the total and epinephrine-sensitive adenyl cyclase activities (7) .
In view of these reports, I ask the following questions: If the Chang cell is derived from a culture of HeLa cell and not from a human liver biopsy as reported (2) (3) . We indicted the cells as being HeLa cell contaminants because they possess a group of chromosomes originally described by Miller et al. (4) for HeLa cells. These "markers" consist of chromosomes whose banding patterns coincide with those of portions of specific human chromosomes, however rearranged (translocations, misdivision, nondisjunction). Besides these "Miller markers," many HeLa strains share other identical markers which serve to characterize closely related strains of HeLa or the culprits in HeLa contamination of other cultures. In fact, we communicated to Chang that some markers that we observed in the "liver cells" were identical to some observed in the HeLa-contaminated cultures from Russian laboratories (5). In every culture analyzed to date, the cells that exhibit "Miller markers" and others also lack a Y chromosome and produce type A (fast moving)
G6PD.
A sample of "Chang liver cells" supplied by the ATCC was studied recently by O'Brien (6) for additional enzyme polymorphism. The 
